Frontiers in Cancer Biotechnology Research

Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.

Research Articles

Science Unboxed: Your Cheat Sheet to Cutting-Edge Discovery

Discover how journal roundups help navigate the vast world of scientific research, with a spotlight on the gut microbiome's role in chemotherapy effectiveness.

Nolan Perry
Aug 09, 2025

The Temozolomide Tango: Partnering Drugs to Outsmart Brain Metastases

Exploring synergistic strategies combining temozolomide with other agents to treat brain metastases, including radiation, targeted therapies, and immunotherapies.

Thomas Carter
Aug 09, 2025

The Sweet Science: How Sri Lanka's Mango Bark Fights Cancer Cells

Discover how Sri Lankan mango bark extracts show potent anti-cancer properties against breast and ovarian cancer cells while sparing healthy cells.

Mason Cooper
Aug 09, 2025

Biapigenin: Nature's Double Agent Against Cancer

Discover how biapigenin, a potent flavonoid dimer, acts as a PPARγ modulator with significant anticancer properties through multiple molecular pathways.

Paisley Howard
Aug 09, 2025

The Gene Therapy Patent Puzzle: Protecting Breakthroughs in the Genetic Revolution

Exploring the complex patent landscape of gene therapy, including CRISPR battles, manufacturing challenges, and breakthrough case studies in genetic medicine.

Gabriel Morgan
Aug 09, 2025

The Architects of Discovery: Inside ICAHMS 2017's Programme Committee

An in-depth look at the International Programme Committee behind ICAHMS 2017 and their role in shaping medical science conferences

Allison Howard
Aug 09, 2025

Double Blockade: How Dual-Target Drugs Are Revolutionizing Breast Cancer Treatment

Exploring the synergistic effects of dual-target drugs in overcoming resistance in HER2-positive breast cancer treatment.

Levi James
Aug 09, 2025

The Consortium Gambit: How Academic Alliances Are Forging a New Era of Open Science

How open access consortia are transforming scientific publishing through collective action and billion-dollar negotiations.

Henry Price
Aug 09, 2025

Unlocking Rare Cancers: The Breakthrough Bispecific Antibody Targeting NRG1 Fusions

Breakthrough research on zenocutuzumab, a bispecific antibody targeting NRG1 fusion-positive cancers, with results from the eNRGy trial showing promising outcomes across multiple tumor types.

Elijah Foster
Aug 09, 2025

The Double Strike: Unraveling the Second Hit in BRCA-Associated Breast Cancer

Exploring the critical second genetic event that transforms BRCA susceptibility into breast cancer malignancy, with insights into mechanisms, clinical implications, and future research directions.

Easton Henderson
Aug 09, 2025

Popular Articles